PsychiatricTimes Members: Login | Register

|     

 
NEWS
Schizophrenia News, Psychiatry News plus CME
www.medpagetoday.com -
Medical News: APA: Major Changes Loom for Bible of Mental Health
www.medpagetoday.com -
Medical News: Cognitive Therapy Helps in Schizophrenia
www.medpagetoday.com -


 
PATIENT RESOURCES
Schizoaffective Disorder Symptoms
psychcentral.com -
Schizoaffective disorder
www.mayoclinic.com -
Invega Antipsychotic Approved for Schizophrenia, Schizoaffective Disorder | Psych Central News
psychcentral.com -
Schizoaffective disorder: MedlinePlus Medical Encyclopedia Image
www.nlm.nih.gov -
Psych Central: Schizophrenia and Psychosis: Schizoaffective Disorder: Support Groups
psychcentral.com -
 
CLINICAL TRIALS
Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder
www.clinicaltrials.gov -
Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
www.clinicaltrials.gov -
A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder
www.clinicaltrials.gov -

Result Pages: 1 2 3 4 5 6 7 8 9 10 Previous



 
CONNECT WITH US
Become a fan on
Facebook
Add us on
Google Plus
Follow us on
Twitter
Join us on
Linked in
Sign up for our
Newsletters
Subscribe to our
RSS Feed

Schizoaffective Disorder
 
LATEST FEATURES
April 2, 2012
Determination and Documentation of Insight in Psychiatric Inpatients
More »
April 2, 2012
Psychopharmacological Treatment to Reduce Suicide Risk
More »
April 2, 2012
Psychopharmacology of Aggression and Violence in Mental Illness
More »
October 5, 2011
Antidepressants: Lifesavers—or Active Placebos?
More »
July 5, 2011
The FDA Advisory Panel on the Reclassification of ECT Devices
More »
May 23, 2011
Nearly Half of Kids in Inpatient Psychiatric Program Receive Antipsychotics
More »
Showing 1 - 6 of 81 results.
Page of 14
First Previous Last
 
JOURNAL SCAN
Review: premorbid IQ is inversely associated with future risk of schizophrenia
ebmh.bmj.com - 5/1/12
Diagnosis of schizophreniform, schizoaffective, schizotypal or psychotic disorders or schizophrenia, using ICD or DSM criteria.
The Ability of Multifamily Groups to Improve Treatment Adherence in Mexican Americans With Schizophrenia [Original Article]
archpsyc.ama-assn.org - 3/5/12

Context  Evidence-based interventions to improve medication adherence among patients with schizophrenia are lacking. Although family psychoeducation has demonstrated efficacy in improving outcomes in schizophrenia, empirical support for its ability to enhance medication adherence is scarce.

Objective  To determine whether a culturally adapted, multifamily group (MFG) therapy would increase medication adherence and decrease psychiatric hospitalizations for Spanish-speakin

Effects of Moderate-Dose Treatment With Varenicline on Neurobiological and Cognitive Biomarkers in Smokers and Nonsmokers With Schizophrenia or Schizoaffective Disorder [Original Article]
archpsyc.ama-assn.org - 12/5/11

Context  The administration of nicotine transiently improves many neurobiological and cognitive functions in schizophrenia and schizoaffective disorder. It is not yet clear which nicotinic acetylcholine receptor (nAChR) subtype or subtypes are responsible for these seemingly pervasive nicotinic effects in schizophrenia and schizoaffective disorder.

Objective  Because α4β2 is a key nAChR subtype for nicotinic actions, we investigated the effect of varenicline t

Negative Symptoms and the Failure to Represent the Expected Reward Value of Actions: Behavioral and Computational Modeling Evidence [Original Article]
archpsyc.ama-assn.org - 2/6/12

Context  Negative symptoms are a core feature of schizophrenia, but their pathogenesis remains unclear. Negative symptoms are defined by the absence of normal function. However, there must be a productive mechanism that leads to this absence.

Objective  To test a reinforcement learning account suggesting that negative symptoms result from a failure in the representation of the expected value of rewards coupled with preserved loss-avoidance learning.

Design 

Only 10% of people with schizophrenia show sustained improvements over 3 years
ebmh.bmj.com - 2/1/12
2327 adults treated for schizoaffective disorders or schizophrenia ( DSM-IV) and participating in the United States Schizophrenia Care and Assessment Program ( US-SCAP).

Result Pages: 1 2 3 4 Next


 
MEDLINE
Diagnostic criteria for schizoaffective disorder.
pubmed.gov - 1/1/12
22243039 2012 01 16 2012 03 28 1744-8360 12 1 Jan Expert Rev Neurother 1-3 Heckers Stephan S eng Editorial England Expert Rev Neurother 101129944 1473-7175 IM diagnosis Research/Reviews.
Cognitive-behavioral therapy for obsessive-compulsive disorder as a comorbidity with schizophrenia or schizoaffective disorder.
pubmed.gov - 1/1/12
22123432 2011 12 14 2012 04 05 1423-0348 81 1 Psychother Psychosom 58-60 Tundo Antonio A Salvati Loretta L Di Spigno Daniela D Cieri Luca L Parena Anita A Necci Roberta R Sciortino Stefania S eng Clinical Trial Letter Research Support, Non-U.S.
Distinct facial processing in schizophrenia and schizoaffective disorders.
pubmed.gov - 1/1/12
Although schizophrenia and schizoaffective disorders have both similar and differing clinical features, it is not well understood whether similar or differing pathophysiological processes mediate patients' cognitive functions. Using psychophysical methods, this study compared the performances of schizophrenia (SZ) patients, patients with schizoaffective disorder (SA), and a healthy control group in two face-related cognitive tasks: emotion discrimination, which tested perception of facial affect, and identity discrimination, which tested perception of non-affective facial features. Compared to healthy controls, SZ patients, but not SA patients, exhibited deficient performance in both fear and happiness discrimination, as well as identity discrimination. SZ patients, but not SA patients, also showed impaired performance in a theory-of-mind task for which emotional expressions are identified based upon the eye regions of face images. This pattern of results suggests distinct processing
A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder.
pubmed.gov - 1/1/12
Quetiapine is often prescribed at higher than approved doses. We investigated the safety, tolerability, and efficacy of quetiapine > 800 mg/d.|A trial was carried out from October 2003-September 2005 in 19 referral centers. Patients with DSM-IV schizophrenia or schizoaffective disorder were randomized on the basis of persistent symptoms of moderate severity (< 30% improvement in total Positive and Negative Syndrome Scale score after 4 weeks of quetiapine). The 8 week, double-blind study compared continuation of quetiapine 800 mg/d (n = 43) versus 1,200 mg/d (n = 88). The primary outcome measure was emergent or worsening parkinsonism (Simpson-Angus Scale). Secondary outcomes were adverse events, metabolic side effects, and symptom severity.|Mean doses obtained were 799 mg/d and 1,144 mg/d in the 800-mg/d and > 800-mg/d groups, respectively. Emergent or deteriorating parkinsonism in the high-dose group was 3.1% greater (95% CI, -7.8% to 14.0%; P = .76) than in the 800-mg/d group, a
Treatment of HIV in outpatients with schizophrenia, schizoaffective disorder and bipolar disease at two county clinics.
pubmed.gov - 12/1/11
Despite a high prevalence of HIV in patients with serious mental health disorders, there is little information in the literature regarding details of their HIV treatment. The objective of this paper is to assess factors associated with the success of HIV therapy in people with schizophrenia, schizoaffective, and bipolar disease. The methods used are retrospective, post-study chart review, and clinician questionnaire at two HIV county clinics. Forty-nine (4.8%) study patients were identified, 51% of whom achieved an undetectable HIV viral load. These patients tended to have less drug use (42% vs. 68%), more ongoing psychiatric visits (70% vs. 58%) and were more apt to take psychiatric medicines (70% vs. 40%) than patients with detectable HIV viral loads. Both groups had many missed appointments. We were surprised to find that many patients were successful with HIV treatment despite substance abuse, uncontrolled psychiatric symptoms, and lack of psychiatric care. Missing clinic

Result Pages: 1 2 3 4 5 6 Next


 
PRACTICE GUIDELINES
ec300032.qxd
www.acponline.org -
Patients who satisfied any of the following criteria on the basis of automated records of physician diagnosis and visits were excluded: diagnosis of bipolar disorder, schizophrenia, or schizoaffective disorder dur- ing ... bipolar disorder
National Guideline Clearinghouse | Practice guideline for the treatment of patients with schizophrenia. Second edition.
www.guidelines.gov -
Practice guideline for the treatment of patients with schizophrenia. Second edition.
Effective Clinical Practice
www.acponline.org -
Patients who satisfied any of the following criteria on the basis of automated records of physician diagnosis and visits were excluded: diagnosis of bipolar disorder, schizophrenia, or schizoaffective disorder during the

Result Pages: 1 2 Next




 
FROM PHYSICIANS PRACTICE
Work-Life Balance Obstacles: Be Smart with Your Medical Charts
Jennifer Frank, MD,  May 22, 2012
Here are 10 tips to improve documentation at your medical practice to get you out of the office and back home to spend time with your family.
Making Public Health Policy and Economics a Priority
Bryan R. Fine, MD, MPH,  May 21, 2012
Public health as an important part of an allopathic, clinical program may be intuitive to some, but implementing it is still a challenge.
Establishing the Chain Of Command at Your Medical Practice
Shelly K. Schwartz,  May 21, 2012
Clear guidelines on practice reporting structures will empower employees to work more effectively.
Using Pinterest to Market Your Medical Practice
Jenny Conviser, PsyD,  May 18, 2012
Pinterest is quickly becoming the next big social media outlet, so here's an easy guide on how your practice can get online and connect with patients.
How to Close Your Medical Practice the Right Way
Sue Jacques,  May 16, 2012
Whether you've decided to retire, relocate, or retreat from practice, you can reduce the pain for your patients and staff by following these five guidelines.
 
COMMENTS
 
CAREER CENTER


 
COUCH IN CRISIS

The Loman Family’s Lessons for the Old Psychiatrist
Psychiatric Times,  May 21, 2012
Is it Time for Re-institutionalization?
Psychiatric Times,  April 20, 2012
New Guidelines Shake Up Treatment of Agitation
March 27, 2012
What Should a Therapist Do in These Situations?
Psychiatric Times,  March 22, 2012
Going Green is Sexy
Psychiatric Times,  March 20, 2012